Li J H, Driver C R, Munsiff S S, Yip R, Fujiwara P I
Tuberculosis Control Program, New York City Department of Health, New York, New York 10007, USA.
Int J Tuberc Lung Dis. 2003 May;7(5):451-7.
A large urban tuberculosis control program.
To examine changes in tuberculosis incidence and characteristics of cases in New York City (NYC), and assess the epidemiology of tuberculosis among non-US-born persons.
Tuberculosis surveillance data (1995-1999) for NYC were analyzed.
Tuberculosis incidence decreased by 56.6% in US-born and 19.6% in non-US-born persons (age-adjusted) over the study period. The decline in tuberculosis incidence among US-born persons was more substantial in the first half of the study period (23-24%) than in the second half (13-15%). The greatest decline in incidence was among US-born Hispanic or Black males aged 25-64. However, although there was an overall decline in incidence among non-US-born persons, there was no significant change in any sex or racial/ethnic subgroup. The percent of multidrug-resistant (MDR) cases among non-US-born patients remained stable, but recent arrivals accounted for 79% of non-US-born MDR-TB patients in 1999, a significant increase from 16% in 1997.
Continuing current tuberculosis control efforts and treatment of immigrants with latent tuberculosis infection are of highest priority for reducing incident cases in NYC. Global collaboration towards earlier detection and treatment of active tuberculosis cases in high incidence countries is also essential.
一个大型城市结核病控制项目。
研究纽约市结核病发病率及病例特征的变化,并评估非美国出生人群中的结核病流行病学情况。
分析了纽约市1995 - 1999年的结核病监测数据。
在研究期间,美国出生人群的结核病发病率下降了56.6%,非美国出生人群下降了19.6%(年龄调整后)。美国出生人群的结核病发病率在研究期前半段下降幅度更大(23 - 24%),后半段为(13 - 15%)。发病率下降幅度最大的是25 - 64岁的美国出生的西班牙裔或黑人男性。然而,尽管非美国出生人群的发病率总体有所下降,但任何性别或种族/族裔亚组均无显著变化。非美国出生患者中耐多药(MDR)病例的比例保持稳定,但1999年新抵达者占非美国出生的耐多药结核病患者的79%,较1997年的16%有显著增加。
持续当前的结核病控制措施以及对潜伏性结核感染的移民进行治疗,是纽约市减少新发病例的首要任务。全球合作以便在高发病率国家更早地发现和治疗活动性结核病例也至关重要。